Effect of Indacaterol on Inspiratory Capacity (IC)

NCT01012765 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

173

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Indacaterol
DRUG: Tiotropium
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals